Výsledky vyhledávání - "The Brighton Collaboration Chorioamnionitis Working Group"

Chorioamnionitis: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data

Publikováno v: Vaccine, 37(52), 7610-7622. Elsevier
Vaccine
Dipòsit Digital de la UB
Universidad de Barcelona
Recercat. Dipósit de la Recerca de Catalunya
instname

Chorioamnionitis is a term encompassing a broad spectrum of disease during pregnancy that is characterized by inflammation and/or infection of intrauterine structures such as the placenta, the chorion and amnion. The clinical presentation of chorioam

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bc187dccf7dae381cb56c7aeb4ef7d7
http://hdl.handle.net/2445/147227

Zobrazit plný text záznamu

Akademický článek

Chorioamnionitis: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.

Autor: Kachikis A; University of Washington, Seattle, WA, USA., Eckert LO; University of Washington, Seattle, WA, USA., Walker C; University of Washington, Seattle, WA, USA., Bardají A; ISGlobal, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain., Varricchio F; Independent Consultant Vaccinologist, Wakefield, RI, USA., Lipkind HS; Yale University School of Medicine, New Haven, CT, USA., Diouf K; Brigham and Women's Hospital, Boston, MA, USA., Huang WT; Taiwan Centers for Disease Control, Taipei, Taiwan., Mataya R; Loma Linda University, Loma Linda, CA, USA; University of Malawi College of Medicine, Malawi., Bittaye M; Edward Francis Small Teaching Hospital, Banjul, The Gambia; Medical Research Council - The Gambia at London School of Hygiene and Tropical Medicine, Fajara, The Gambia; University of The Gambia School of Medicine & Allied Health Sciences, The Gambia., Cutland C; Medical Research Council: Respiratory and Meningeal Pathogens Research Unit, Johannesburg, South Africa; Department of Science and Technology National Research Foundation, Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Boghossian NS; Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA., Mallett Moore T; Sanofi Pasteur, USA., McCall R; University of North Carolina, Chapel Hill, NC, USA., King J; Sanofi Pasteur, USA., Mundle S; Government Medical College, Nagpur, India., Munoz FM; Baylor College of Medicine, Houston, TX, USA., Rouse C; Indiana University School of Medicine, Indianapolis, IN, USA., Gravett M; University of Washington, Seattle, WA, USA., Katikaneni L; Medical University of South Carolina, Charleston, SC, USA., Ault K; University of Kansas Medical Center, Kansas City, KS, USA., Klein NP; Kaiser Permanente Vaccine Study Centre, Oakland, CA, USA., Roberts DJ; Massachusetts General Hospital, Boston, MA, USA., Kochhar S; Global Healthcare Consulting, India; Erasmus University Medical Center, Rotterdam, the Netherlands; University of Washington, Seattle, WA, USA., Chescheir N; University of North Carolina, Chapel Hill, NC, USA. Electronic address: secretariat@brightoncollaboration.org.

Publikováno v: Vaccine [Vaccine] 2019 Dec 10; Vol. 37 (52), pp. 7610-7622.